Screener
Moderna MRNA EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Moderna in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The source filing: Moderna’s 8-K, filed July 31, 2026. Open the filing →
- Filed
- Jul 31, 2026, 7:03 AM EDT
- Accession
- 0001682852-26-000147
FAQ
- What is Moderna's EPS (basic)?
- Moderna (MRNA) reported EPS (basic) of -$1.97 in Q2 2026.
- How has Moderna's EPS (basic) changed year-over-year?
- Moderna's EPS (basic) increased by 7.5% year-over-year, from -$2.13 to -$1.97.
- What is the long-term trend for Moderna's EPS (basic)?
- Over 4 years (2021 to 2025), Moderna's EPS (basic) has grown at a -30.0% compound annual growth rate (CAGR), from $30.31 to -$7.27.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.
Ask your AI about Moderna's eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude